Statistics for Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1
Total visits
| views | |
|---|---|
| Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1 | 10 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 6 |
| July 2024 | 0 |
Top country views
| views | |
|---|---|
| Switzerland | 6 |
Top city views
| views | |
|---|---|
| Biberist | 6 |